SEO URLwww.firestrike.ai/deals/lakewood-amedex-biotherapeutics-inc-labt-ipo-2026
ipoAnnounced · Apr 23, 2026Biotechnology (clinical-stage; infectious disease antimicrobials)
Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc. (LABT) IPO
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Offering size
—
Company
Lakewood-Amedex Biotherapeutics Inc.
Exchange
NASDAQ Capital
Status
expected
Lakewood-Amedex Biotherapeutics Inc. is in the IPO process (expected). Indicative offering scale: Not disclosed. Price range (when disclosed): n/a. Sector: Biotechnology (clinical-stage; infectious disease antimicrobials). Headquarters context: University Park, Florida, United States. Expected listing context: NASDAQ Capital / LABT.
This page summarizes publicly available information about the offering as of 2026-04-23. Dates, filing status, and proceeds may change as the issuer updates disclosures.
Deal timeline
Announced
Apr 23, 2026
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology (clinical-stage; infectious disease antimicrobials). Figures and status may change as sources update.
Sources: · Primary article · FireStrike proprietary index